Acquisition of Anoikis Resistance Up-regulates Caveolin-1 Expression in Human Non-small Cell Lung Cancer Cells

被引:0
|
作者
Halim, Hasseri [2 ]
Luanpitpong, Sudjit [2 ]
Chanvorachote, Pithi [1 ]
机构
[1] Chulalongkorn Univ, Fac Pharmaceut Sci, Dept Physiol & Pharmacol, Bangkok 10330, Thailand
[2] Chulalongkorn Univ, Fac Pharmaceut Sci, Pharmaceut Technol Int Program, Bangkok 10330, Thailand
关键词
Anoikis resistance; cancer adaptation; caveolin-1; mRNA transcription; lung cancer; H460; cells; METASTASIS; INHIBITION; PATHWAY; MATRIX; GROWTH;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Anoikis is a key inhibitory step in the process of cancer cell metastasis. Knowledge regarding the adaptive response resulting in resistance to anoikis may benefit the development of new therapies. Materials and Methods: Anoikis-resistant cells were generated from anoikis-sensitive lung carcinoma cells and the underlying mechanism for this process was investigated. Results: Culturing H460 cells under suspended conditions caused spontaneous generation of anoikis-resistant H_AR1 and H_AR2 cells. We found that anoikis resistance in these cells caused caveolin-1 (CAV1) up-regulation. Using short hairpin RNA (shRNA), we confirmed that depletion of CAV1 rendered anoikis-resistant H_AR2 cells sensitive to anoikis. Furthermore, this study revealed that the acquisition of anoikis resistance induced CAV1 up-regulation through induction of CAV1 mRNA transcription. Conclusion: Our findings show CAV1 to be a key player in anoikis resistance and provide a novel mechanism regarding cancer cell adaptation, resulting in acquisition of anoikis resistance in lung cancer cells.
引用
收藏
页码:1649 / 1658
页数:10
相关论文
共 50 条
  • [41] Expression of engrailed homeobox 2 regulates the proliferation, migration and invasion of non-small cell lung cancer cells
    Lin, Xiangxiao
    Liu, Xincun
    Gong, Cunqi
    ONCOLOGY LETTERS, 2018, 16 (01) : 536 - 542
  • [42] Increased MALAT1 expression contributes to cisplatin resistance in non-small cell lung cancer
    Cui, Yong
    Li, Guanlong
    Zhang, Xin
    Dai, Fangfang
    Zhang, Rongxiang
    ONCOLOGY LETTERS, 2018, 16 (04) : 4821 - 4828
  • [43] Prognostic implications of ezrin and phosphorylated ezrin expression in non-small cell lung cancer
    Jin, Tiefeng
    Jin, Jingchun
    Li, Xiangyu
    Zhang, Songnan
    Choi, Yun Ho
    Piao, Yingshi
    Shen, Xionghu
    Lin, Zhenhua
    BMC CANCER, 2014, 14
  • [44] Disordered expression of HOX genes in human non-small cell lung cancer
    Abe, M
    Hamada, JI
    Takahashi, O
    Takahashi, Y
    Tada, M
    Miyamoto, M
    Morikawa, T
    Kondo, S
    Moriuchi, T
    ONCOLOGY REPORTS, 2006, 15 (04) : 797 - 802
  • [45] Overcoming Osimertinib Resistance in Advanced Non-small Cell Lung Cancer
    Lim, J. U.
    CLINICAL ONCOLOGY, 2021, 33 (10) : 619 - 626
  • [46] Sonic hedgehog pathway expression in non-small cell lung cancer
    Savani, Malvi
    Guo, Yan
    Carbone, David P.
    Csiki, Ildiko
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2012, 4 (05) : 225 - 233
  • [47] The Expression of Ezrin and Its Significance in Non-small Cell Lung Cancer
    Ma Lan
    Wu Hao
    Sun Jing
    Liu Lian-ke
    JOURNAL OF INTERNATIONAL TRANSLATIONAL MEDICINE, 2014, 2 (03): : 408 - 412
  • [48] CD74-ROS1 G2032R mutation transcriptionally up-regulates Twist1 in non-small cell lung cancer cells leading to increased migration, invasion, and resistance to crizotinib
    Gou, Wenfeng
    Zhou, Xuejiao
    Liu, Zi
    Wang, Lijing
    Shen, Jiwei
    Xu, Xiaobo
    Li, Zengqiang
    Zhai, Xin
    Zuo, Daiying
    Wu, Yingliang
    CANCER LETTERS, 2018, 422 : 19 - 28
  • [49] miRNA-124 down-regulates SOX8 expression and suppresses cell proliferation in non-small cell lung cancer
    Xie, Chao
    Han, Yunwei
    Liu, Yi
    Han, Lei
    Liu, Jie
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (10): : 6534 - 6542
  • [50] Cytoplasmic RAP1 mediates cisplatin resistance of non-small cell lung cancer
    Xiao, Lu
    Lan, Xiaoying
    Shi, Xianping
    Zhao, Kai
    Wang, Dongrui
    Wang, Xuejun
    Li, Faqian
    Huang, Hongbiao
    Liu, Jinbao
    CELL DEATH & DISEASE, 2017, 8 : e2803 - e2803